COVID-19: Risk for Cytokine Targeting in Chronic Inflammatory Diseases?

Nature Reviews Immunology - United Kingdom
doi 10.1038/s41577-020-0312-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy